{"id":"W2786087266","doi":"10.2147/jir.s157358","title":"Clinical utility of ustekinumab in Crohn’s disease","year":2018,"lang":"en","type":"review","venue":"Journal of Inflammation Research","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"UCB Pharma; Canadian Institutes of Health Research; Eisai; Biogen; Amgen; Pfizer; Canadian Association of Gastroenterology","keywords":"Ustekinumab; Medicine; Crohn's disease; Interleukin 23; Tumor necrosis factor alpha; Immunology; Inflammatory bowel disease; Vedolizumab; Adalimumab; Internal medicine; Oncology; Interleukin; Disease; Cytokine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009009028,0.0002519168,0.000760496,0.0009194459,0.0001633707,0.0008426516,0.0002206909,0.0005215707,0.002688581],"category_scores_gemma":[0.001518265,0.00007691252,0.0005186655,0.0008041851,0.0003158145,0.0005292643,0.000348648,0.0007826486,0.0008297825],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004310926,"about_ca_system_score_gemma":0.0005042807,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005432879,"about_ca_topic_score_gemma":0.001117226,"domain_scores_codex":[0.9996322,0.0001410078,0.00007322984,0.00003440807,0.00009597922,0.00002312709],"domain_scores_gemma":[0.9994876,0.0002324295,0.000130923,0.00001248599,0.00009996122,0.00003654221],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.000702393,0.00005939712,0.002366337,0.009813292,0.0001928231,0.0005612503,0.00007635874,0.0001679919,0.001849155,0.002562711,0.01598796,0.9656603],"study_design_scores_gemma":[0.0006211214,0.001477963,0.01789343,0.0136643,0.001054068,0.008436563,0.0002521442,0.0005307011,0.004050027,0.006875722,0.9450902,0.0000537833],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001935734,0.992417,0.000224329,0.001373111,0.0003051989,0.00001042373,0.00005161879,0.00001395878,0.003668699],"genre_scores_gemma":[0.04833854,0.9458354,0.000988378,0.001484281,0.0009931329,0.00003322141,0.0001444473,0.000009401529,0.002173253],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002688581,"threshold_uncertainty_score":0.008994222,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1819119401562638,"score_gpt":0.4971550086703956,"score_spread":0.3152430685141318,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}